Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Samnick

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Anticancer Research|March 2, 2005
Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomasBernd F M Romeike, Dirk Hellwig, Axel Heimann, et al.
Oncotarget|October 4, 2014
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationConstantin Lapa, Katharina Lückerath, Uwe Malzahn, et al.
The Open Neurology Journal|November 20, 2008
Cerebral and Extracranial Neurodegeneration are Strongly Coupled in Parkinson's DiseaseJörg Spiegel, Dirk Hellwig, Wolfgang H Jost, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2007
Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's diseaseJörg Spiegel, Dirk Hellwig, Georgios Farmakis, et al.
Clinical Nuclear Medicine|October 24, 2002
Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningiomaDirk Hellwig, Samuel Samnick, Johannes Reif, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomasSamuel Samnick, Bernd F Romeike, Thomas Lehmann, et al.
Nuclear Medicine and Molecular Imaging|June 6, 2014
Systemic Endoradiotherapy with Carrier-Added 4-[(131)I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory GliomaRichard P Baum, Andreas Kluge, Franz Josef Gildehaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2005
FP-CIT and MIBG scintigraphy in early Parkinson's diseaseJörg Spiegel, Marc-Oliver Möllers, Wolfgang H Jost, et al.
Clinical Neurology and Neurosurgery|June 29, 2024
PET imaging for a very early detection of rapid eye movement sleep behaviour disorder and Parkinson's disease - A model-based cost-effectiveness analysisFrancis Fezeu, Omar F Jbara, Ahda Jbarah, et al.
Zeitschrift Fur Medizinische Physik|June 13, 2013
Compressed sensing for reduction of noise and artefacts in direct PET image reconstructionDominik Richter, Thomas C Basse-Lüsebrink, Thomas Kampf, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Anticancer Research|March 2, 2005
Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomasBernd F M Romeike, Dirk Hellwig, Axel Heimann, et al.
Oncotarget|October 4, 2014
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationConstantin Lapa, Katharina Lückerath, Uwe Malzahn, et al.
The Open Neurology Journal|November 20, 2008
Cerebral and Extracranial Neurodegeneration are Strongly Coupled in Parkinson's DiseaseJörg Spiegel, Dirk Hellwig, Wolfgang H Jost, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2007
Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's diseaseJörg Spiegel, Dirk Hellwig, Georgios Farmakis, et al.
Clinical Nuclear Medicine|October 24, 2002
Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningiomaDirk Hellwig, Samuel Samnick, Johannes Reif, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomasSamuel Samnick, Bernd F Romeike, Thomas Lehmann, et al.
Nuclear Medicine and Molecular Imaging|June 6, 2014
Systemic Endoradiotherapy with Carrier-Added 4-[(131)I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory GliomaRichard P Baum, Andreas Kluge, Franz Josef Gildehaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2005
FP-CIT and MIBG scintigraphy in early Parkinson's diseaseJörg Spiegel, Marc-Oliver Möllers, Wolfgang H Jost, et al.
Clinical Neurology and Neurosurgery|June 29, 2024
PET imaging for a very early detection of rapid eye movement sleep behaviour disorder and Parkinson's disease - A model-based cost-effectiveness analysisFrancis Fezeu, Omar F Jbara, Ahda Jbarah, et al.
Zeitschrift Fur Medizinische Physik|June 13, 2013
Compressed sensing for reduction of noise and artefacts in direct PET image reconstructionDominik Richter, Thomas C Basse-Lüsebrink, Thomas Kampf, et al.
Pageof 10